FDA's Crawford cleared of affair

An inspector general's probe of a relationship between acting FDA commissioner Lester Crawford and a senior official of the agency concluded that he gave conflicting evidence in the investigation but could not corroborate if he was having an illicit affair. As a result, Republicans moved to push forward with his nomination as commissioner. Investigators said, however, that the unidentified woman told investigators that Crawford had provided improper assistance in gaining a promotion for her, which Crawford denied. Another FDA official contradicted Crawford's statement that he had endorsed the woman for the promotion, saying that he had, in fact, questioned her qualifications.

- read this article from The Washington Post

Suggested Articles

In this week's EuroBiotech Report, AstraZeneca plans 2020 lupus filing, Roche's SMA trial hits endpoint and Kiadis cuts staff in R&D pivot.

In our EuroBiotech roundup this week, NEC and Vaximm ink cancer vaccine pact, Compugen posts cancer data and Lunac raises cash.

Biotech venture fund ATAI Life Sciences has partnered with artificial intelligence drug discovery specialist Cyclica to form a new JV.